We are live on ! Find out more

TLOG

TetraLogic Pharmaceuticals Corporation

TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

26 hedge funds and large institutions have $146K invested in TetraLogic Pharmaceuticals Corporation in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New

Increased

Maintained

Reduced

Closed

37% more funds holding

Funds holding: 19 → 26 (+7)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

29% less capital invested

Capital invested by funds: $205K → $146K (-$59K)

Holders

Holders Change

Holders Change %

+36.84%

% of All Funds

0.69%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

–

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	VKH Virtu KCG Holdings New York	+$25.3K
2	Susquehanna International Group Bala Cynwyd, Pennsylvania	+$19K
3	Citadel Advisors Miami, Florida	+$6.34K
4	UBS Group Zurich, Switzerland	+$5.69K
5	TSS Two Sigma Securities New York	+$3.69K

Top Sellers

Rank	Fund	Capital Flow
1	Morgan Stanley New York	-$1.02K
2	Renaissance Technologies New York	-$693
3	Bank of New York Mellon New York	-$387
4	GC Guggenheim Capital Chicago, Illinois	-$106

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Renaissance Technologies New York	$30K	-$693	-3,000	-2%
2	2 Vanguard Group Malvern, Pennsylvania	$25K	+$2.01K	+8,700	+6%
3	VKH 3 Virtu KCG Holdings New York	$17K	+$25.3K	+109,634	New
4	4 Susquehanna International Group Bala Cynwyd, Pennsylvania	$13K	+$19K	+82,370	New
5	5 Geode Capital Management Boston, Massachusetts	$12K	+$20	+85	+0.1%
6	6 Goldman Sachs New York	$7K	+$513	+2,220	+5%
7	7 Morgan Stanley New York	$6K	-$1.02K	-4,407	-9%
8	8 California Public Employees Retirement System Sacramento, California	$6K	–	–	–
9	9 HighTower Advisors Chicago, Illinois	$5K	–	–	–
10	10 UBS Group Zurich, Switzerland	$4K	+$5.69K	+24,630	+923%
11	11 Citadel Advisors Miami, Florida	$4K	+$6.34K	+27,442	New
12	GC 12 Guggenheim Capital Chicago, Illinois	$3K	-$106	-460	-2%
13	TSS 13 Two Sigma Securities New York	$3K	+$3.69K	+15,983	New
14	14 Bank of New York Mellon New York	$2K	-$387	-1,676	-12%
15	15 Creative Planning Overland Park, Kansas	$2K	–	–	–
16	MWP 16 MYCIO Wealth Partners Philadelphia, Pennsylvania	$2K	–	–	–
17	17 Northern Trust Chicago, Illinois	$2K	–	–	–
18	18 Wolverine Trading Chicago, Illinois	$2K	+$2.36K	+10,200	New
19	BWA 19 Burt Wealth Advisors North Bethesda, Maryland	$1K	–	–	–
20	BFA 20 BlackRock Fund Advisors San Francisco, California	–	+$46	+201	+10%
21	21 Bank of America Charlotte, North Carolina	–	+$196	+849	New
22	WIC 22 Woodmont Investment Counsel Nashville, Tennessee	–	+$283	+1,225	New

TLOG Hedge Fund Activity: Q3 2016 in Review

26 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2016, worth a combined $146K — down 29% from $205K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TLOG positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $25.3K. The largest seller was Morgan Stanley, cutting an estimated $1.02K.

26 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2016, up from 19 in Q2 2016.
Funds reported $146K of TetraLogic Pharmaceuticals Corporation stock for Q3 2016, down 29% quarter-over-quarter.
7 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2016 and 0 closed out, a net change of +7 holders.
The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2016 was Virtu KCG Holdings, an estimated $25.3K added.
The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2016 was Morgan Stanley, an estimated $1.02K sold.

Based on aggregated 13F filings for Q3 2016.

TetraLogic Pharmaceuticals Corporation TLOG